Contact this trialFirst, we need to learn more about you.
Ablation Catheter
FlexAbility SE Ablation Catheter for Ventricular Tachycardia
Recruiting1 award5 criteria
Nashville, Tennessee
This trial aims to confirm the safety and effectiveness of the FlexAbility SE catheter for treating ventricular tachycardia. The device works by creating small scars in the heart to block abnormal electrical signals, helping to restore a normal heart rhythm. The study focuses on patients with this serious heart condition who may not respond well to other treatments. Catheter ablation has emerged as an important and effective treatment option for many recurrent ventricular arrhythmias.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service